Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September
06. September 2022 06:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results
15. August 2022 16:05 ET
|
Helius Medical Technologies, Inc.
-- Net proceeds from August 2022 financing and cash on hand expected to fund operations through 2023 ---- Company to host call at 4:30pm today -- NEWTOWN, Pa., Aug. 15, 2022 (GLOBE NEWSWIRE) --...
Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022
10. August 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering
05. August 2022 08:38 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™
12. Juli 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., July 12, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...
Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting
06. Juni 2022 07:05 ET
|
Helius Medical Technologies, Inc.
-- Study finds significant improvement in gait deficit in multiple sclerosis patients using translingual neurostimulation (“PoNS Therapy®”) combined with a therapeutic exercise program -- -- Poster...
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®
01. Juni 2022 07:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference
31. Mai 2022 08:36 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 31, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
24. Mai 2022 16:05 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 24, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...
Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program
17. Mai 2022 07:30 ET
|
Helius Medical Technologies, Inc.
NEWTOWN, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the...